Atrion Co. (NASDAQ:ATRI) announced a quarterly dividend on Wednesday, May 22nd, Wall Street Journal reports. Stockholders of record on Friday, June 14th will be paid a dividend of 1.35 per share by the medical instruments supplier on Friday, June 28th. This represents a $5.40 dividend on an annualized basis and a dividend yield of 0.61%. The ex-dividend date is Thursday, June 13th.

Atrion has increased its dividend payment by an average of 15.6% per year over the last three years and has raised its dividend every year for the last 16 years.

Shares of Atrion stock traded up $0.41 during trading on Wednesday, reaching $883.98. The stock had a trading volume of 230 shares, compared to its average volume of 6,885. The firm has a market cap of $1.63 billion, a price-to-earnings ratio of 46.43 and a beta of 0.39. Atrion has a 52 week low of $567.50 and a 52 week high of $948.03.

Atrion (NASDAQ:ATRI) last issued its quarterly earnings results on Wednesday, May 8th. The medical instruments supplier reported $5.07 EPS for the quarter. Atrion had a return on equity of 16.89% and a net margin of 22.76%. The company had revenue of $41.61 million for the quarter.

Separately, BidaskClub upgraded Atrion from a “hold” rating to a “buy” rating in a report on Thursday, May 30th.

In other Atrion news, Director Ronald Nicholas Spaulding sold 200 shares of the company’s stock in a transaction that occurred on Tuesday, May 28th. The stock was sold at an average price of $903.00, for a total value of $180,600.00. Following the sale, the director now owns 2,158 shares in the company, valued at $1,948,674. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 22.07% of the stock is owned by corporate insiders.

COPYRIGHT VIOLATION WARNING: “Atrion Co. (NASDAQ:ATRI) Announces $1.35 Quarterly Dividend” was originally posted by Watch List News and is the sole property of of Watch List News. If you are accessing this article on another site, it was copied illegally and reposted in violation of U.S. & international copyright laws. The correct version of this article can be accessed at

Atrion Company Profile

Atrion Corporation develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications worldwide. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments.

Featured Article: Trading Ex-Dividend

Dividend History for Atrion (NASDAQ:ATRI)

Receive News & Ratings for Atrion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atrion and related companies with's FREE daily email newsletter.